Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.

Molad, Y; Gorshtein, A; Wysenbeek, A J; Guedj, D; Majadla, R; Weinberger, A; Amit-Vazina, M

Molad, Y; Gorshtein, A; Wysenbeek, A J; Guedj, D; Majadla, R; Weinberger, A; Amit-Vazina, M.

Affiliation

Molad Y; Rheumatology Unit, Rabin Medical Center, Petah Tiqva, Israel. ymolad@clalit.org.il

Lupus ; 11(6): 356-61, 2002.

Article in En | MEDLINE | ID: mdl-12139373

Subject(s)

Antimalarials/therapeutic use; Hydroxychloroquine/therapeutic use; Lupus Erythematosus, Systemic/drug therapy; Adolescent; Adrenal Cortex Hormones/therapeutic use; Adult; Aged; Aged, 80 and over; Antirheumatic Agents/therapeutic use; Cyclophosphamide/therapeutic use; Female; Humans; Longitudinal Studies; Lupus Erythematosus, Systemic/complications; Male; Middle Aged; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hydroxychloroquine / Lupus Erythematosus, Systemic / Antimalarials Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2002 Document type: Article Affiliation country: Israel Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links